Laparascopic Surgery Does Not Improve Outcomes Over Open Resection for Rectal Cancer
the ONA take:
Compared with open surgery, laparascopic surgery fails to improve outcomes for patients with stage 2 or 3 rectal cancer, two studies published in JAMA have shown.
In the first study, researchers sought to determine whether laparoscopic resection is noninferior to open resection in patients with more advanced-stage rectal cancer.
Researchers randomly assigned 240 patients to undergo laparoscopic resection and 222 to undergo open resection. Results showed that the minimally invasive surgery did not improve cancer control as well as the open surgery did.
“Pending clinical oncologic outcomes, the findings do not support the use of laparoscopic resection in these patients,” the authors of the first study conclude.
In the second study, researchers enrolled 475 patients with T1 to T3 rectal adenocarcinoma less than 15 cm from the anal verge and randomly assigned them to undergo open laparotomy and rectal resection or laparoscopic rectal resection.
Results of this study also demonstrated that laparoscopic surgery was not noninferior to open surgery for successful resection; however, overall quality of surgery was high among patients who underwent the laparoscopic surgery.
“The findings do not provide sufficient evidence for the routine use of laparoscopic surgery,” the authors of the second study conclude.
Compared with open surgery, laparascopic surgery fails to improve outcomes for patients with stage 2 or 3 rectal cancer.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|